INCYTE GENOMICS INC
S-3/A, EX-23.1, 2000-08-01
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: INCYTE GENOMICS INC, S-3/A, 2000-08-01
Next: INCYTE GENOMICS INC, S-3/A, EX-23.2, 2000-08-01



<PAGE>   1

                                                                    EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3 No. 333-33500) and related Prospectus of Incyte
Genomics, Inc. for the registration of 2,000,000 shares of its common stock and
to the incorporation by reference therein of our report dated January 24, 2000
with respect to the consolidated financial statements of Incyte Genomics, Inc.
(formerly known as Incyte Pharmaceuticals, Inc.) included in its Annual Report
(Form 10-K) for the year ended December 31, 1999, filed with the Securities and
Exchange Commission.


                                             ERNST & YOUNG LLP


Palo Alto, California
July 31, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission